Sangamo Therapeutics, Inc. (SGMO) Financials

SGMO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 165.3 million 82.4 million
2023-09-30 219.7 million 84.8 million
2023-06-30 325.1 million 91.4 million
2023-03-31 440.6 million 105.0 million

SGMO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -53.2 million 6.1 million
2023-09-30 -50.0 million 6.2 million
2023-06-30 -66.3 million 6.8 million
2023-03-31 -76.5 million 8.3 million

SGMO Net Income

No data available :(

SGMO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 81.0 million - 38.1 million
2023-09-30 132.1 million - 35.0 million
2023-06-30 143.1 million - 36.4 million
2023-03-31 205.4 million - 37.7 million

SGMO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 177.6 million
2023-09-30 177.2 million
2023-06-30 174.3 million
2023-03-31 169.2 million

SGMO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 2.7 million 51.2 million 13.1 million -2.9 million
2023-09-30 2.7 million 57.1 million 13.9 million -
2023-06-30 5.5 million 63.0 million 16.0 million -
2023-03-31 10.2 million 63.2 million 18.1 million -

SGMO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.0 million 3.0 million
2023-09-30 9.4 million 9.5 million
2023-06-30 6.8 million 4.3 million
2023-03-31 158.0 million 3.5 million

SGMO

Price: $0.56

52 week price:
0.29
1.78

Earnings Per Share: -1.48 USD

P/E Ratio: -0.39

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 882100

Ebitda: -12.6 million

Market Capitalization: 115.3 million

Links: